Atlas Trials

A Study of the Safety and Preliminary Efficacy of NKG001 in Pediatric Patients With Type 1 or Type 2 Spinal Muscular Atrophy

Clinical trial NCT07617779 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07617779
Sponsor
Nikegen Pharmaceutical (Hangzhou) Company Limited
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Spinal Muscular Atrophy (SMA)
Start date
2024-04-21
Primary completion
2028-04-23
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.